NCT00321594View on ClinicalTrials.gov

Belinostat in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

August 31, 2010

Study Completion Date

October 31, 2012

Conditions
Adult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerLocalized Unresectable Adult Primary Liver CancerRecurrent Adult Primary Liver Cancer
Interventions
DRUG

belinostat

Given IV

Trial Locations (2)

53792

University of Wisconsin Hospital and Clinics, Madison

119074

Cancer Therapeutics Research Group, Singapore

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00321594 - Belinostat in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery | Biotech Hunter | Biotech Hunter